− Takeda to receive exclusive option to license global rights to ACI-24.060, a potential first-in-class active immunotherapy designed to delay or slow Alzheimer’s disease progression
FPT Software has entered into a partnership with Mendix, Siemens' industry-leading low-code application development platform. Through this collaboration, FPT Sof...